Literature DB >> 8824879

Mutational hotspots in the LAMB3 gene in the lethal (Herlitz) type of junctional epidermolysis bullosa.

S Kivirikko1, J A McGrath, L Pulkkinen, J Uitto, A M Christiano.   

Abstract

The Herlitz type of junctional epidermolysis bullosa (H-JEB) is a severe blistering disease affecting the skin and mucous membranes, and laminin 5 has been implicated as the candidate gene/protein system for most patients with H-JEB. In this study, we have examined a cohort of 14 families with H-JEB for mutations in the LAMB3 gene. Premature termination codon mutations were delineated in both alleles of each proband in all pedigrees. Interestingly, two recurrent mutations, R42X and R635X, were noted in over 50% of the mutant LAMB3 alleles. These nonsense mutations occurred at CpG dinucleotide sequences, suggesting hypermutability of 5-methylcytosine to thymine. Additional evidence suggested that R42X and R635X represent mutational hotspots. First, the inheritance of R635X in a homozygous individual on two different genetic backgrounds was demonstrated by haplotype analysis. Furthermore, in one family, R42X was shown to be inherited on the maternal allele which lacked this mutation, suggesting that it arose as a result of maternal germline mutation. Elucidation of these two hotspot mutations will facilitate screening of additional JEB patients for the underlying mutations.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8824879     DOI: 10.1093/hmg/5.2.231

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  21 in total

1.  Digenic junctional epidermolysis bullosa: mutations in COL17A1 and LAMB3 genes.

Authors:  M Floeth; L Bruckner-Tuderman
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

Review 2.  Multiple hits during early embryonic development: digenic diseases and holoprosencephaly.

Authors:  Jeffrey E Ming; Maximilian Muenke
Journal:  Am J Hum Genet       Date:  2002-10-22       Impact factor: 11.025

3.  Maternal uniparental disomy of chromosome 1 with reduction to homozygosity of the LAMB3 locus in a patient with Herlitz junctional epidermolysis bullosa.

Authors:  L Pulkkinen; F Bullrich; P Czarnecki; L Weiss; J Uitto
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

4.  Novel and recurrent mutations in the laminin-5 genes causing lethal junctional epidermolysis bullosa: molecular basis and clinical course of Herlitz disease.

Authors:  Christiane Mühle; Qiu-Jie Jiang; Alexandra Charlesworth; Leena Bruckner-Tuderman; Guerrino Meneguzzi; Holm Schneider
Journal:  Hum Genet       Date:  2004-11-05       Impact factor: 4.132

5.  Epidermolysis bullosa. I. Molecular genetics of the junctional and hemidesmosomal variants.

Authors:  R Varki; S Sadowski; E Pfendner; J Uitto
Journal:  J Med Genet       Date:  2006-02-10       Impact factor: 6.318

Review 6.  Laminins: Roles and Utility in Wound Repair.

Authors:  Valentina Iorio; Lee D Troughton; Kevin J Hamill
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-04-01       Impact factor: 4.730

7.  Three novel homozygous point mutations and a new polymorphism in the COL17A1 gene: relation to biological and clinical phenotypes of junctional epidermolysis bullosa.

Authors:  H Schumann; N Hammami-Hauasli; L Pulkkinen; A Mauviel; W Küster; U Lüthi; K Owaribe; J Uitto; L Bruckner-Tuderman
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

8.  In vivo restoration of laminin 5 beta 3 expression and function in junctional epidermolysis bullosa.

Authors:  P B Robbins; Q Lin; J B Goodnough; H Tian; X Chen; P A Khavari
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

Review 9.  Do cell junction protein mutations cause an airway phenotype in mice or humans?

Authors:  Eugene H Chang; Alejandro A Pezzulo; Joseph Zabner
Journal:  Am J Respir Cell Mol Biol       Date:  2011-02-04       Impact factor: 6.914

Review 10.  Defining the role of laminin-332 in carcinoma.

Authors:  Cherise M Guess; Vito Quaranta
Journal:  Matrix Biol       Date:  2009-08-15       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.